NIHR Office for Clinical Research Infrastructure (NOCRI)
The NIHR Office for Clinical Research Infrastructure (NOCRI) has been set up to help public, charity and industry research funders work in partnership with NIHR infrastructure. Equally, it ensures that NIHR-supported Centres, Units, Facilities and Networks can work together to help drive the flow of innovative research for patient benefit.
NOCRI's role is to:
- Champion and support cross-infrastructure working, where this adds significant value.
- Work with leading academic and expert clinical research experts and strengthen enduring relationships between the NIHR, NHS, NHS/university partnerships and biotechnology, pharmaceutical, medical device and diagnostic companies and contract research organisations.
- Promote and enhance the nation’s reputation as a world-class centre for applied clinical research, as well as supporting how the NIHR contributes to Growth.
- Maximise the impact of the NIHR as a whole, by leading work to shorten the time it takes to develop new therapies and medical technologies.
NOCRI support to the NIHR infrastructure:
- NOCRI is in a unique position to support the establishment of national collaborations within the NIHR infrastructure. We look for opportunities where collaborations bring added value and overcome disease and technical challenges
- NOCRI supports the development of infrastructure collaborations in areas including rare diseases, dementia, nutrition, HIV, cancer and nutrition, and statistics
- NOCRI can link together relevant parts of the NIHR infrastructure (e.g. existing collaborations and/or groups)
- NOCRI helps companies work with the right people within the NIHR infrastructure and makes it easy for infrastructure and industry to work together We have an overview of what you have to offer and promote that to industry through the media, case studies, local and international conferences and one-to-one meetings.
NOCRI is a unique resource for the global life sciences industry - improving the quality, efficiency and success of translational research. We enable this by providing:
- fast and easy access to the UK's clinical research infrastructure
- rapid connection to expert investigators and cutting edge technologies
- tools and processes to support collaborative research
In early-phase clinical research, NOCRI provides connections to the country's experimental medicine experts who can help companies understand the potential of their developmental drugs, devices and diagnostics, shortening cycle times and enabling earlier go/no go decisions.
In later-phase research, NOCRI provides rapid links to the NIHR's Clinical Research Network which ensures efficient and effective delivery of larger and multi-centre clinical studies.
Dr David Baghurst General Manager NOCRI
David is General Manager of NOCRI and is also the Director Research Programmes NIHR CCF where his teams manage various policy and research funding programmes.
David has a DPhil from the University of Oxford and MBA from Warwick University. David started his career as a lecturer at Imperial College before leaving academia to manage industrial research and development teams and then science-based business incubator projects. For 15 years David was involved in growing university technology transfer activities and advising international organisations on technology transfer policy and capacity development. David (Chinese name: 贝大卫) was based in China for 5 years. He joined NIHR in 2017.
Dr Peter Sargent, Head of Business Development
Dr Peter Sargent is the Head of Business Development for NOCRI where he leads a team supporting life science companies globally gain access to expertise, facilities and funding from across the NIHR and wider UK health System. His team also works closely with the Department of Health and Social Care, Office for Life Sciences and the Department of International Trade to promote the UK across the globe.
Following obtaining his PhD in Molecular Biology and Biochemistry from King’s College London, Peter has worked with in a variety of In Vitro Diagnostic and Drug Development companies at senior management level, leading R&D and Business Development functions in the development and commercialisation of healthcare products and services. Now working for the NIHR, he utilises his industry experience to support companies in their product development with the aim to bring new technologies and therapies into the NHS.
Dr Matthew Hallsworth, Head of External Relations
Dr Matthew Hallsworth is Head of External Relations for the NIHR Office for Clinical Research Infrastructure (NOCRI). He leads on external stakeholder relations, including engagement with the pharmaceutical industry.
NOCRI works with companies and other research partners to support collaboration with the UK’s expert investigators and research facilities funded by the UK Department of Health, from early-phase translational medicine through to later-phase clinical trials.
Prior to NOCRI Matthew was Head of Communications at the UK Clinical Research Collaboration – a partnership of government, charities, industry, the NHS, academia, regulators and patients focused on improving the clinical research environment in the UK.
Matthew has also had Research Management roles at the medical charity Asthma UK and for the Department of Health’s National R&D Programme.
During his earlier career Matthew was a Research Fellow in Respiratory Medicine at Guy’s & St Thomas’ Hospitals, London, where he completed his PhD on the mechanisms of inflammation in asthma and allergic disease.
Dr Lucy Allen, Head of Infrastructure
Dr Lucy Allen is Head of Infrastructure for the NIHR Office for Clinical Research Infrastructure (NOCRI). Through the NIHR, the Department of Health invests £0.5 billion per year in clinical research infrastructure. Lucy’s role is to maximise the value of this investment by ensuring the infrastructure are working together in a coordinated way to support high quality clinical research delivering benefits for patients and the NIHR. NOCRI works closely the life sciences industry to highlight the wide range of NIHR infrastructure available to support research across the innovation pathway.
Prior to joining the NOCRI team, Lucy was a Department Manager and senior scientist at GE Healthcare, one of the world leaders in radiopharmaceuticals, developing diagnostic imaging agents across numerous disease areas and imaging modalities. Lucy has worked across all phases of discovery from early stage research through development, driving lead candidates into clinical trials and First-In-Man imaging studies.
Lucy gained a PhD in the mechanisms of inflammation in respiratory disease.
NIHR Office for Clinical Research Infrastructure (NOCRI)
5 Montague Close
Tel.: 020 3794 7380